PaxMedica | 8-K: Current report
May 1 17:23 ET
PaxMedica | 8-K: PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101
Apr 23 08:44 ET
PaxMedica | 8-K: PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness
Apr 16 16:41 ET
PaxMedica | DEF 14A: Definitive information statements
Apr 15 16:36 ET
PaxMedica | 8-K: PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission
Apr 11 16:51 ET
PaxMedica | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Apr 3 16:49 ET
PaxMedica | 8-K: Current report
Mar 22 16:09 ET
PaxMedica | 8-K: PaxMedica Releases Updated Company Profile Presentation
Mar 13 08:13 ET
PaxMedica | 8-K: PaxMedica Board of Directors Announces Employee Restricted Stock Grants
Jan 29 17:24 ET
PaxMedica | 8-K: Current report
Jan 12 00:00 ET
PaxMedica | 8-K: The Company Has Demonstrated Compliance with Disclosures Related to the Minimum Shareholder Rights Requirements of Nasdaq Listing Rule 5550(B)(1)
Dec 21, 2023 08:00 ET
PaxMedica | 8-K: Final Cash Payment of $0.2 Million of Outstanding Secured Convertible Promissory Note
Nov 30, 2023 16:07 ET
PaxMedica | 8-K: Disclosure Information of Public Offering in Compliance With Nasdaq Listing Rule 5550(b)(1)
Nov 29, 2023 16:05 ET
PaxMedica | 8-K: PaxMedica Announces Pricing of $7.0 Million Public Offering
Nov 22, 2023 16:24 ET
PaxMedica | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Nov 16, 2023 16:27 ET
PaxMedica | 8-K: PaxMedica, Inc. Announces Third Quarter 2023 Financial Results and Business Update
Nov 15, 2023 19:00 ET
PaxMedica | 8-K: PaxMedica Has Demonstrated Compliance with Nasdaq Bid Price Requirement with Respect to the Common Stock
Nov 14, 2023 19:00 ET
PaxMedica | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Nov 14, 2023 16:15 ET
PaxMedica | 8-K: Financial Condition for the Three Months Ended September 30, 2023 and Entry into a Securities Purchase Agreement
Nov 9, 2023 07:18 ET
PaxMedica | S-1: General form for registration of securities under the Securities Act of 1933
Nov 9, 2023 06:02 ET
No Data
No Data